Author:
Atherton Nicky,Bridle Chris,Brown Deborah,Collins Helen,Dosanjh Sukhdeep,Griffiths Frances,Hennings Susie,Khan Kamran,Lall Ranjit,Lyle Samantha,McShane Rupert,Mistry Dipesh,Nichols Vivien,Petrou Stavros,Sheehan Bart,Slowther Anne-Marie,Thorogood Margaret,Withers Emma,Zeh Peter,Lamb Sarah E.
Funder
Health Technology Assessment Programme
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference37 articles.
1. Rizzi L, Rosset I, Roriz-Cruz M. Global epidemiology of dementia: Alzheimer’s and vascular types. Biomed Res Int. 2014;2014:908915.
2. Rocca WA, Hofman A, Brayne C, Breteler MMB, Clarke M, Copeland JRM, et al. Frequency and distribution of Alzheimer’s disease in Europe: a collaborative study of 1980–1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol. 1991;30(3):381–90.
3. National Institute for Health and Clinical Excellence. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (TA217). London, UK: National Institute for Health and Clinical Excellence; 2011.
4. Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S. Exercise programs for people with dementia. Cochrane Database Syst Rev. 2015;4:CD006489.
5. Vertesi A, Lever JA, Molloy DW, Sanderson B, Tuttle I, Pokoradi L, et al. Standardized Mini-Mental State Examination. Use and interpretation. Can Fam Physician. 2001;47:2018–23.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献